HSBC Holdings
HRTX icon

HSBC Holdings’s Heron Therapeutics HRTX Stock Holding History

HSBC Holdings’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.1K Hold
33,381
– – ﹤0.01% 2845
2025
Q4 		$43.9K Sell
33,381
-53
-0.2% -$65 ﹤0.01% 2874
2025
Q3 		$42K Sell
33,434
-14,851
-31% -$23.5K ﹤0.01% 2652
2025
Q2 		$102K Buy
48,285
+1,180
+3% +$2.41K ﹤0.01% 2846
2025
Q1 		$103K Sell
47,105
-89
-0.2% -$173 ﹤0.01% 2800
2024
Q4 		$71K Sell
47,194
-2,495
-5% -$4.04K ﹤0.01% 2947
2024
Q3 		$99.6K Buy
49,689
+17,746
+56% +$42.4K ﹤0.01% 2802
2024
Q2 		$111K Sell
31,943
-195
-0.6% -$599 ﹤0.01% 2712
2024
Q1 		$89K Buy
+32,138
New +$80.8K ﹤0.01% 2866
2022
Q3 		– Sell
-44,407
Closed -$122K – 3077
2022
Q2 		$122K Buy
44,407
+24,709
+125% +$99.2K ﹤0.01% 3004
2022
Q1 		$112K Buy
+19,698
New +$144K ﹤0.01% 3104
2021
Q2 		– Sell
-16,308
Closed -$263K – 2992
2021
Q1 		$263K Buy
16,308
+4,578
+39% +$81.6K ﹤0.01% 2380
2020
Q4 		$248K Buy
+11,730
New +$204K ﹤0.01% 2698
2020
Q2 		– Sell
-14,683
Closed -$171K – 2751
2020
Q1 		$171K Buy
14,683
+2,443
+20% +$45.9K ﹤0.01% 2349
2019
Q4 		$288K Buy
12,240
+510
+4% +$11.3K ﹤0.01% 2579
2019
Q3 		$217K Buy
+11,730
New +$216K ﹤0.01% 2824
2019
Q2 		– Sell
-10,956
Closed -$268K – 2758
2019
Q1 		$268K Buy
+10,956
New +$287K ﹤0.01% 2403

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

HSBC Holdings's HRTX Position: Q1 2026 in Review

HSBC Holdings held its Heron Therapeutics (HRTX) position steady in Q1 2026 at 33,381 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2845.

HSBC Holdings first reported a position in HRTX in Q1 2019 and has held it in 17 quarters since. The position peaked at $288K in Q4 2019. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • HSBC Holdings held 33,381 shares of Heron Therapeutics worth $26.1K as of Q1 2026.
  • HSBC Holdings left its Heron Therapeutics share count unchanged in Q1 2026.
  • Heron Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2845 holding.
  • HSBC Holdings first reported a position in Heron Therapeutics in Q1 2019 and has held it in 17 quarters since.
  • HSBC Holdings's Heron Therapeutics position peaked at $288K in Q4 2019.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.